Literature DB >> 17645575

Dopamine agonist therapy and cardiac valve dysfunction.

Mark Sherlock1, Richard Steeds, Andy A Toogood.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17645575     DOI： 10.1111/j.1365-2265.2007.02974.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN： 0300-0664            Impact factor:   3.478


× No keyword cloud information.
  1 in total

1.  Long-term cabergoline therapy is not associated with valvular heart disease in patients with prolactinomas.

Authors:  Sophie Vallette; Karim Serri; Juan Rivera; Patricia Santagata; Sophie Delorme; Natasha Garfield; Nora Kahtani; Hugues Beauregard; Nahla Aris-Jilwan; Ghislaine Houde; Omar Serri
Journal:  Pituitary       Date:  2009       Impact factor: 4.107
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.